Loading…
Loading…
Ref. No.
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
19 May 2026, 12:00 pmClosed
PROCUREMENT OF EXP MED STORE FOR FY 26 27
9308066
GEM/2026/B/7520872
Two Packet Bid
Lignocaine HCl 2 percen without Adrenaline 30 ml Inj,Lignocaine HCl 2 percen with Adrenaline 1ratio
Samba, Jammu And Kashmir
Total value wise evaluation
BOQ
6 documents required · 6 mandatory
1 yrs
50%
Exempted
Yes
19 May 2026
9 May 2026
19 May 2026
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) | Spec |
|---|---|---|---|---|---|---|
| 1 | Lignocaine HCl 2 percen without Adrenaline 30 ml Inj | 60 | Amp | SAMBA | 21 | |
| 2 | Lignocaine HCl 2 percen with Adrenaline 1ratio 80000 30 ml Inj | 30 | Amp | SAMBA | 21 | |
| 3 | Atropine Sulphate 0 point 6 mg 1 ml Inj | 180 | Amp | SAMBA | 21 | |
| 4 | Midazolam 5 mg 1 ml Inj | 6 | Amp | SAMBA | 21 | |
| 5 | Diclofenac 25 mg per ml IP 3 ml Inj | 750 | Amp | SAMBA | 21 | |
| 6 | Pethedine 50 mg 1 ml Inj | 30 | Amp | SAMBA | 21 | - |
| 7 | Adrenaline Tartrate 1ratio 1000 1 ml Inj | 420 | Amp | SAMBA | 21 | |
| 8 | Noradrenaline Bitartrate 2 mg per ml 2 ml Inj | 12 | Amp | SAMBA | 21 | - |
| 9 | Promethazine HCl 2 point 5 percen 25 mg per ml 2 ml Inj | 30 | Amp | SAMBA | 21 | |
| 10 | Lorazepam 2 mg per ml 2 ml Inj | 180 | Amp | SAMBA | 21 | - |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9308066.pdf
GEM_BID • 0.25 MB
spec_doc_re_03_2026-05-09-10-10-48_adea5eb86515b19ad2ab994fa6feae65.pdf
BOQ • 0.27 MB
boq_item_sample_file_2026-05-09-10-10-48_56ba38702f99d52b2c8849caacba6708.csv
BOQ • 0.00 MB
UDRCERT_0f082c3f-a306-45ca-a9d11778306841464_JERIL.pdf
GEM_OTHER • 0.23 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .